These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18516420)

  • 1. [Noncompliance with drug therapy for glaucoma].
    Castro AN; Mesquita WA
    Arq Bras Oftalmol; 2008; 71(2):207-14. PubMed ID: 18516420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance in patients prescribed eyedrops for glaucoma.
    Patel SC; Spaeth GL
    Ophthalmic Surg; 1995; 26(3):233-6. PubMed ID: 7651690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.
    Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M
    Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker eyedrops and nocturnal arterial hypotension.
    Hayreh SS; Podhajsky P; Zimmerman MB
    Am J Ophthalmol; 1999 Sep; 128(3):301-9. PubMed ID: 10511024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Timolol eyedrops in ophthalmological practice].
    Widder W
    Klin Monbl Augenheilkd; 1980 Mar; 176(3):430-40. PubMed ID: 7421007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T; Giorgis AT; Shibeshi W
    BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncompliance with medical treatment among glaucoma patients in Oman--a cross-sectional descriptive study.
    Khandekar R; Shama Mel-S; Mohammed AJ
    Ophthalmic Epidemiol; 2005 Oct; 12(5):303-9. PubMed ID: 16272050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical investigation of medication adherence of glaucoma patients].
    Wu HY; Yin JF
    Zhonghua Yan Ke Za Zhi; 2010 Jun; 46(6):494-8. PubMed ID: 21055192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with timolol treatment in glaucoma.
    Rotchford AP; Murphy KM
    Eye (Lond); 1998; 12 ( Pt 2)():234-6. PubMed ID: 9683946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2-year long-term treatment of chronic glaucoma with timolol eyedrops].
    Plane C; Sansorgne R; Renaud C; Jouan JP
    Bull Soc Ophtalmol Fr; 1979; 79(6-7):615-21. PubMed ID: 546558
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Text Parsing-Based Identification of Patients with Poor Glaucoma Medication Adherence in the Electronic Health Record.
    Hamid MS; Valicevic A; Brenneman B; Niziol LM; Stein JD; Newman-Casey PA
    Am J Ophthalmol; 2021 Feb; 222():54-59. PubMed ID: 32926847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.
    Park MH; Kang KD; Moon J;
    Jpn J Ophthalmol; 2013 Jan; 57(1):47-56. PubMed ID: 23065047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of three kinds of anti-glaucoma eyedrops on ocular blood flow].
    Zhao J; Mao J; Sui R
    Zhonghua Yan Ke Za Zhi; 2000 Nov; 36(6):425-30. PubMed ID: 11853641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eyedrops or surgery?
    White TC
    Ophthalmic Surg; 1990 Apr; 21(4):300. PubMed ID: 2362758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Timolol Eyedrops].
    Hørven I
    Tidsskr Nor Laegeforen; 1980 Feb; 100(4):235-6. PubMed ID: 7376160
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension.
    Shibuya T; Kashiwagi K; Tsukahara S
    Ophthalmologica; 2003; 217(1):31-8. PubMed ID: 12566870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.